Market Cap: $12.72B
Market Cap: $12.72B
Open
$30.26
Prev. Close
$30.51
High
$30.38
Low
$29.89
Smith & Nephew plc, along with its subsidiaries, operates globally as a developer, manufacturer, marketer, and seller of medical technology. Its orthopaedic division offers knee implants for replacement procedures and hip implants for joint reconstruction.
Smith & Nephew plc trades on the New York Stock Exchange under the ticker SNN, priced in USD.
Smith & Nephew plc has a market capitalisation of $12.72B, based on its latest share price.
SNN trades at 19.79 times its trailing 12-month earnings.
Over the past 52 weeks SNN has traded between $26.12 and $37.09.
Yes. Smith & Nephew plc's dividend yields 2.63% at the current share price, paying out 52% of its earnings.
Profitable, with a net margin of 10.1% over the last 12 months.
The analyst consensus rating for SNN is Hold.
Deepak S. Nath is the CEO of Smith & Nephew plc, which is headquartered in Watford.
Generated automatically from reported financial data. General information only, not financial advice.
Smith & Nephew Faces Critical Evaluations Amidst Industry Insights In the latest analysis by Jim Cramer on "Mad Money," Smith & Nephew plc finds itself under scrutiny as the host recommends that inves…
Smith & Nephew Faces Critical Evaluation Amid Market Recommendations In the latest episode of "Mad Money," host Jim Cramer critically evaluates Smith & Nephew plc, a prominent player in the medical te…
Smith & Nephew: Navigating Market Volatility Amid Economic Uncertainty In recent days, the healthcare sector has felt the ripple effects of broader market volatility, particularly as investor sentimen…
Smith & Nephew's Position Amid Market Volatility Smith & Nephew plc, a prominent player in the global medical technology sector, operates in an environment characterized by fluctuating investor sentim…